Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BOTOX®(BOTOX is a Registered Trade Mark of Allergan, Inc) Injection 50 and 100 Treatment of Equinus Foot Due to Lower Limb Spasticity in Juvenile Cerebral Palsy Patients Aged 2-year or Older: Investigation of Patient Background Characteristics

NCT01332474 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01332474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01332474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BOTOX®(BOTOX is a Registered Trade Mark of Allergan, Inc) Injection 50 and 100 Treatment of Equinus Foot Due to Lower Limb Spasticity in Juvenile Cerebral Palsy Patients Aged 2-year or Older: Investigation of Patient Background Characteristics
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
May 31, 2010
Completion date
August 31, 2010
Enrollment
326 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

spasticity, post-stroke